XML 38 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Segment and Geographical Information (Tables)
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,

 
July 1,

 
June 30,

 
July 1,

(In millions)
 
2018

 
2017

 
2018

 
2017

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,569

 
$
1,405

 
$
3,068

 
$
2,768

Analytical Instruments
 
1,311

 
1,166

 
2,568

 
2,218

Specialty Diagnostics
 
932

 
862

 
1,879

 
1,728

Laboratory Products and Services
 
2,550

 
1,792

 
4,963

 
3,491

Eliminations
 
(284
)
 
(235
)
 
(547
)
 
(450
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
6,078

 
4,990

 
11,931

 
9,755

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
522

 
448

 
1,039

 
881

Analytical Instruments
 
291

 
232

 
537

 
424

Specialty Diagnostics
 
253

 
234

 
496

 
467

Laboratory Products and Services
 
337

 
245

 
617

 
461

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,403

 
1,159

 
2,689

 
2,233

 
 
 
 
 
 
 
 
 
Cost of revenues charges
 
(5
)
 
(1
)
 
(8
)
 
(32
)
Selling, general and administrative charges, net
 
(3
)
 
(7
)
 
(11
)
 
(38
)
Restructuring and other costs, net
 
(17
)
 
(22
)
 
(62
)
 
(46
)
Amortization of acquisition-related intangible assets
 
(441
)
 
(380
)
 
(885
)
 
(748
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
937

 
749

 
1,723

 
1,369

Other expense, net (b)
 
(131
)
 
(123
)
 
(283
)
 
(240
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
806

 
$
626

 
$
1,440

 
$
1,129

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
29

 
$
32

 
$
60

 
$
65

Analytical Instruments
 
17

 
17

 
35

 
34

Specialty Diagnostics
 
18

 
18

 
37

 
35

Laboratory Products and Services
 
66

 
30

 
129

 
60

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
130

 
$
97

 
$
261

 
$
194

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,

 
July 1,

 
June 30,

 
July 1,

(In millions)
 
2018

 
2017

 
2018

 
2017

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,569

 
$
1,405

 
$
3,068

 
$
2,768

Analytical Instruments
 
1,311

 
1,166

 
2,568

 
2,218

Specialty Diagnostics
 
932

 
862

 
1,879

 
1,728

Laboratory Products and Services
 
2,550

 
1,792

 
4,963

 
3,491

Eliminations
 
(284
)
 
(235
)
 
(547
)
 
(450
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
6,078

 
4,990

 
11,931

 
9,755

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
522

 
448

 
1,039

 
881

Analytical Instruments
 
291

 
232

 
537

 
424

Specialty Diagnostics
 
253

 
234

 
496

 
467

Laboratory Products and Services
 
337

 
245

 
617

 
461

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,403

 
1,159

 
2,689

 
2,233

 
 
 
 
 
 
 
 
 
Cost of revenues charges
 
(5
)
 
(1
)
 
(8
)
 
(32
)
Selling, general and administrative charges, net
 
(3
)
 
(7
)
 
(11
)
 
(38
)
Restructuring and other costs, net
 
(17
)
 
(22
)
 
(62
)
 
(46
)
Amortization of acquisition-related intangible assets
 
(441
)
 
(380
)
 
(885
)
 
(748
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
937

 
749

 
1,723

 
1,369

Other expense, net (b)
 
(131
)
 
(123
)
 
(283
)
 
(240
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
806

 
$
626

 
$
1,440

 
$
1,129

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
29

 
$
32

 
$
60

 
$
65

Analytical Instruments
 
17

 
17

 
35

 
34

Specialty Diagnostics
 
18

 
18

 
37

 
35

Laboratory Products and Services
 
66

 
30

 
129

 
60

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
130

 
$
97

 
$
261

 
$
194

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,

 
July 1,

 
June 30,

 
July 1,

(In millions)
 
2018

 
2017

 
2018

 
2017

 
 
 
 
 
 
 
 
 
Revenues (c)
 
 
 
 
 
 
 
 
United States
 
$
2,914

 
$
2,484

 
$
5,670

 
$
4,861

China
 
648

 
512

 
1,189

 
953

Other
 
2,516

 
1,994

 
5,072

 
3,941

 
 
 
 
 
 
 
 
 
Consolidated revenues
 
$
6,078

 
$
4,990

 
$
11,931

 
$
9,755

(c)
Revenues are attributed to countries based on customer location.